NRP1 and prostate neoplasm: Studies have shown that NRP-1 was upregulated in liver cancer [20], prostate tumor [21], gastric cancer [22], breast cancer [23], lung carcinomas, etc. Overexpression of NRP-1 was found to promote tumor angiogenesis as well as the growth and proliferation of cancer cells.